Sahebi, Firoozeh, Iacobelli, Simona, Sbianchi, Giulia, Koster, Linda, Blaise, Didier, Remenyi, Peter, Russell, Nigel H., Ljungman, Per, Kobbe, Guido, Apperley, Jane, Trneny, Marek, Krejci, Marta, Wiktor-Jedrzejczak, Wieslaw, Sanchez, James F., Schaap, Nicolaas ORCID: 0000-0001-7696-4752, Isaksson, Cecilia, Lenhoff, Stig, Browne, Paul ORCID: 0000-0001-5310-1487, Scheid, Christof, Wilson, Keith M. O., Yakoub-Agha, Ibrahim ORCID: 0000-0003-4524-8782, Muniz, Soledad Gonzalez, Schoenland, Stefan, Morris, Curly, Garderet, Laurent and Kroeger, Nicolaus (2018). Incidence of Second Primary Malignancies after Autologous Transplantation for Multiple Myeloma in the Era of Novel Agents. Biol. Blood Marrow Transplant., 24 (5). S. 930 - 937. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1523-6536

Full text not available from this repository.

Abstract

The advent of novel agents for multiple myeloma (MM) is cause for a re-examination of the incidence of second primary malignancies (SPM5). We examined the SPM rate in MM patients who were enrolled in the prospective observational CALM (Collaboration to Collect Autologous Transplant outcome in Lymphoma and Myeloma) study. Between 2008 and 2012, 3204 patients with MM underwent a first autologous hematopoietic stem cell transplantation. Plerixafor was used as a mobilizing agent for patients with poor (or potentially poor) stem cell mobilization as defined by the respective centers. A total of 135 patients developed SPM5, with a cumulative incidence of 5.3% (95% confidence interval, 4.4 to 6.3) at 72 months. Ninety-four patients developed solid tumors, 30 developed hematologic malignancies, and 11 developed an SPM of an unknown type. The cumulative incidence of known hematologic and solid malignancies were 1.4% and 3.6%, respectively, at 72 months. In a univariate analysis, use of radiotherapy, type of induction regimen, hematopoietic stem cell dose, poor mobilizer status, plerixafor use, and sex did not influence the cumulative incidence of SPMs. Only age over 65 years was statistically associated with an increased incidence. Overall, the incidence of SPMs was comparable to earlier estimations of SPMs in MM. (C) 2018 American Society for Blood and Marrow Transplantation.

Item Type: Journal Article
Creators:
CreatorsEmailORCIDORCID Put Code
Sahebi, FiroozehUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Iacobelli, SimonaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Sbianchi, GiuliaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Koster, LindaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Blaise, DidierUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Remenyi, PeterUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Russell, Nigel H.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Ljungman, PerUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Kobbe, GuidoUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Apperley, JaneUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Trneny, MarekUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Krejci, MartaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Wiktor-Jedrzejczak, WieslawUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Sanchez, James F.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Schaap, NicolaasUNSPECIFIEDorcid.org/0000-0001-7696-4752UNSPECIFIED
Isaksson, CeciliaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Lenhoff, StigUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Browne, PaulUNSPECIFIEDorcid.org/0000-0001-5310-1487UNSPECIFIED
Scheid, ChristofUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Wilson, Keith M. O.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Yakoub-Agha, IbrahimUNSPECIFIEDorcid.org/0000-0003-4524-8782UNSPECIFIED
Muniz, Soledad GonzalezUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Schoenland, StefanUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Morris, CurlyUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Garderet, LaurentUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Kroeger, NicolausUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
URN: urn:nbn:de:hbz:38-187588
DOI: 10.1016/j.bbmt.2018.01.006
Journal or Publication Title: Biol. Blood Marrow Transplant.
Volume: 24
Number: 5
Page Range: S. 930 - 937
Date: 2018
Publisher: ELSEVIER SCIENCE INC
Place of Publication: NEW YORK
ISSN: 1523-6536
Language: English
Faculty: Unspecified
Divisions: Unspecified
Subjects: no entry
Uncontrolled Keywords:
KeywordsLanguage
STEM-CELL TRANSPLANTATION; LENALIDOMIDE MAINTENANCE; MYELODYSPLASTIC SYNDROME; THERAPY; LEUKEMIA; METAANALYSIS; SECONDARY; NEOPLASMS; ADULTS; RISKMultiple languages
Hematology; Immunology; TransplantationMultiple languages
Refereed: Yes
URI: http://kups.ub.uni-koeln.de/id/eprint/18758

Downloads

Downloads per month over past year

Altmetric

Export

Actions (login required)

View Item View Item